600721.SS SHH
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd
1W: -9.4%
1M: -5.7%
3M: +90.0%
YTD: +40.5%
1Y: +62.2%
3Y: +80.6%
5Y: +190.0%
¥13.11 ($1.96)
+0.16 (+1.24%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
$33M
-59.0% ▼
Capital Expenditures
$18M
+26.9% ▲
5Y CAGR: +36.7%
Free Cash Flow
$15M
-73.2% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$27M
-62.0% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $60M | -$35M | $13M | $41M | $41M |
| Depreciation & Amort. | $25M | $26M | $25M | $19M | $0 |
| Stock-Based Comp. | $2M | $8M | $3M | $0 | $0 |
| Change in Working Capital | -$74M | -$8M | -$27M | -$22M | -$64M |
| Other Non-Cash Items | $19M | $59M | $45M | $41M | $56M |
| Operating Cash Flow | $35M | $53M | $62M | $80M | $33M |
| — Investing Activities — | |||||
| Capital Expenditures | -$6M | -$2M | -$17M | -$25M | -$18M |
| Acquisitions (Net) | $1K | $18K | $0 | $0 | $65K |
| Investment Purchases | -$58M | -$64M | -$167M | -$535M | $0 |
| Investment Sales | $65M | $65M | $167M | $537M | $0 |
| Other Investing | $0 | -$9M | $2M | $65K | -$4M |
| Investing Cash Flow | $297K | -$11M | -$16M | -$22M | -$22M |
| — Financing Activities — | |||||
| Net Debt Issuance | $6M | -$6M | $0 | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | -$39K | -$121K | $0 | $0 | $0 |
| Other Financing | $0 | $13M | $20M | $12M | $3M |
| Financing Cash Flow | $6M | $6M | $20M | $12M | $3M |
| Net Change in Cash | $41M | $49M | $66M | $70M | $27M |
| Cash End of Period | $87M | $136M | $202M | $272M | $299M |
| Free Cash Flow | $29M | $51M | $45M | $56M | $15M |